Loading...
•
Dec 31, 2019
ResMed Q2 2020 Earnings Report
ResMed's Q2 2020 results showed strong revenue growth and improved profitability.
Key Takeaways
ResMed reported a strong December quarter with double-digit top-line growth and gross margin expansion. Revenue increased by 13% to $736.2 million, and non-GAAP operating profit was up by 21%. The company saw continued strong customer demand for new products, particularly in masks and accessories.
Revenue increased 13% year-over-year to $736.2 million.
Non-GAAP operating profit increased 21% year-over-year.
GAAP diluted earnings per share were $1.10, while non-GAAP diluted earnings per share were $1.21.
Software as a Service revenue increased by 37%.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
No specific forward guidance was provided in the earnings report.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...